|Articles|December 4, 2018

Microbiology & toxicology testing services for the medical device and pharmaceutical industries.

Wickham Laboratories Ltd is a trusted name in the pharmaceutical and medical device industries with over 50 years of experience in contract testing, research and consultancy.

At Wickham Laboratories, we maintain only the highest standard of quality at all stages while providing rapid turnaround for both routine testing and bespoke one-off projects.

 

Whether assisting a start-up company demonstrating proof of concept, or working with a global medical device manufacturer, our expert technicians recognise the importance of delivering an exceptional service by taking the time with every client to fully understand their individual requirements.

 

We are routinely inspected by the MHRA, FDA and Home Office, and offer the opportunity for clients to conduct audits on a regular basis.

 

Our services include:

  • Biocompatibility testing services; including cytotoxicity, sensitisation, implantation, systemic toxicity, intracutaneous reactivity and local irritation testing.

  • In vitro testing services; including bacterial endotoxin testing (LAL), cytotoxicity testing, the monocyte activation test (MAT), ELISA, BCA and Western blot.

  • Microbial identification; rapid identification (MALDI-ToF).

  • Quality control testing services including; bioburden, environmental monitoring, microbial limits (TAMC / TYMC and absence of specified pathogens), potable water and sterility testing.

  • Stability storage and testing.

  • Validation testing services; including antimicrobial / preservative efficacy testing, biological indicator enumeration, log reduction and microbial ingress challenges.

  • Toxicology testing services; including abnormal toxicity testing, potency bioassays and RPT.

Please contact +44 (0)1329 226600 for further information regarding our services.

 

Contact Details:

Company name: Wickham Laboratories Ltd
Website: www.wickhamlabs.co.uk
E-mail:mail@wickhamlabs.co.uk

Related to this article

Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
AAPS PharmSci 360: CMC Strategies, Part 3
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.